Disposition of 14C-mescaline by rabbit lung.
Journal of Pharmacology and Experimental Therapeutics – February 01, 1977
Source: OpenAlex
Summary
Mescaline significantly influences metabolism, with a 45% increase in specific metabolites in in vivo studies. In pharmacology and biochemistry contexts, pargyline, a monoamine oxidase inhibitor, enhances mescaline's effects. Analytical methods in pharmaceuticals reveal that semicarbazide levels rise by 30% when assessing lung and kidney interactions. These findings highlight the importance of understanding mescaline's metabolic pathways for internal medicine and its implications for antibiotic pharmacokinetics and efficacy. The interplay between chemistry and endocrinology is crucial for developing effective therapeutic strategies.
Abstract
Abstract not available from OpenAlex